Circumvenous ablation for treatment of atrial fibrillation

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/512223

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Atrial fibrillation is the most common abnormal heart rhythm. It causes symptoms that may be disabling but also increases the risk of stroke and death. The lifetime risk of developing atrial fibrillation is 20-25%. Treatment with medications is often unsuccessful and is never curative. Recently a new minimally invasive procedure was developed that may cure some patients. The purpose of this clinical trial is to improve the curative technique to broaden the application of the new procedure.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $341,844.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nutrigenomics and personalised nutrition

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

arrhythmia | arrhythmias | atrial fibrillation | cardiac arrhythmia | cardiovascular disease | electrophysiology

Related Links